E. Stadtmauer
Impact in
- Hematology top 5%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
-
- Peptidase Inhibition and Analysis
Papers in ⓘ
- Hematology 11
- Multiple Myeloma Research and Treatments 5
- Hematopoietic Stem Cell Transplantation 4
- Acute Myeloid Leukemia Research 3
-
- Hematological disorders and diagnostics 3
- Co-authors
- Dina Ben‐Yehuda (4 shared papers)Sagar Lonial (4 shared papers)Pieter Sonneveld (4 shared papers)Anthony Boral (4 shared papers)Paul G. Richardson (4 shared papers)David Irwin (4 shared papers)Jesús F. San Miguel (4 shared papers)Donna Reece (4 shared papers)
- Journals
- Blood (5 papers)Journal of Clinical Oncology (2 papers)HemaSphere (1 paper)Bone Marrow Transplantation (1 paper)Leukemia (1 paper)
- Partner nations
- United StatesNetherlandsCanada
In The Last Decade
E. Stadtmauer
16 papers receiving 352 citations
Peers
Comparison fields: 5 of 47
- Hematology 271
- Oncology 168
- Genetics 55
- Molecular Biology 184
- Pathology and Forensic Medicine 37
Countries citing papers authored by E. Stadtmauer
This map shows the geographic impact of E. Stadtmauer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Stadtmauer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Stadtmauer more than expected).
Fields of papers citing papers by E. Stadtmauer
This network shows the impact of papers produced by E. Stadtmauer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Stadtmauer. The network helps show where E. Stadtmauer may publish in the future.
Co-authors
The 25 scholars most cited alongside E. Stadtmauer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 130 | |
| 2 | 1993 | 79 | |
| 3 | 2005 | 35 | |
| 4 | Phase I trial of TALL-104 cells in patients with refractory metastatic breast cancer. | 2000 | 33 |
| 5 | 2005 | 19 | |
| 6 | 2004 | 14 | |
| 7 | 2005 | 13 | |
| 8 | 1996 | 12 | |
| 9 | 1993 | 7 | |
| 10 | 2000 | 5 | |
| 11 | 2006 | 5 | |
| 12 | Autologous bone marrow transplantation. A review of the principles and complications. | 1993 | 4 |
| 13 | 2004 | 3 | |
| 14 | Bone marrow purging with oligodeoxynucleotides. | 1996 | 3 |
| 15 | 2019 | 2 | |
| 16 | 4-Hydroperoxycyclophosphamide purged autologous bone marrow transplantation of relapsed, responding non-Hodgkin's lymphoma with granulocyte colony stimulating factor support results in reliable hematopoietic recovery. | 1994 | 1 |
About E. Stadtmauer
E. Stadtmauer is a scholar working on Hematology, Emergency Medicine, Oncology, Orthopedics and Sports Medicine and Genetics, having authored 16 papers that have together received 365 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Hematopoietic Stem Cell Transplantation (4 papers), Protein Degradation and Inhibitors (3 papers), Lymphoma Diagnosis and Treatment (3 papers), Cancer Treatment and Pharmacology (3 papers), Acute Myeloid Leukemia Research (3 papers), Hematological disorders and diagnostics (3 papers) and Chronic Lymphocytic Leukemia Research (2 papers). The work is most often cited by research in Hematology (271 citations), Oncology (168 citations), Genetics (55 citations), Molecular Biology (184 citations) and Pathology and Forensic Medicine (37 citations). E. Stadtmauer has collaborated with scholars based in United States, Netherlands and Canada. Frequent co-authors include Dina Ben‐Yehuda, Sagar Lonial, Pieter Sonneveld, Anthony Boral, Paul G. Richardson, David Irwin, Jesús F. San Miguel, Donna Reece, Mario Boccadoro and James D. Cavenagh. Their work appears in journals such as Blood, Journal of Clinical Oncology, HemaSphere, Bone Marrow Transplantation and Leukemia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.